Pierre LEBLOND
Centre Oscar Lambret · IHOP · Centre Oscar Lambret, Lille, France
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Pierre LEBLOND as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:44 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT03585465 · Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid TumorsCentre Oscar Lambret · terminated · Childhood Solid Tumor · study director
- Ph2/Ph3NCT02265770 · An International Clinical Program for the Diagnosis and Treatment of Children With EpendymomaCentre Leon Berard · recruiting · Childhood Ependymoma · principal investigator
- Ph2NCT02197637 · Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade GliomaCentre Oscar Lambret · completed · Low-Grade Glioma · principal investigator
- Ph1NCT02115074 · Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic GliomasCentre Oscar Lambret · completed · Glioma · study director
- Ph1NCT01165333 · Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine GliomaCentre Oscar Lambret · completed · Diffuse Intrinsic Pontine Glioma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:44 UTC. The ranking covers the 200 most relevant of 19 PubMed records, and a shared surname and initials can bring in a namesake. All 19 on PubMed
- Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors.Neuro Oncol · 2011122 citationsRCR 3.2
- Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet.Br J Haematol · 200559 citationsRCR 1.9
- Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial.JAMA Oncol · 202345 citationsRCR 4.1
- 40 citationsRCR 1.2
- 36 citationsRCR 1.0
- Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase II trial PNET HR+5.Neuro Oncol · 202135 citationsRCR 2.1
- Phase I study of non-pegylated liposomal doxorubicin in children with recurrent/refractory high-grade glioma.Cancer Chemother Pharmacol · 201533 citationsRCR 1.2
- Intracranial ependymomas in childhood: recurrence, reoperation, and outcome.Childs Nerv Syst · 200531 citationsRCR 1.0
- Phase II study of temozolomide and topotecan (TOTEM) in children with relapsed or refractory extracranial and central nervous system tumors including medulloblastoma with post hoc Bayesian analysis: A European ITCC study.Pediatr Blood Cancer · 202021 citationsRCR 1.0
- Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours.Eur J Cancer · 201018 citationsRCR 0.5